Autopsy report · NCT00132730
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Cause of deathNo reason given
Life of this trial
- Registered 1 year 2 months after it had already started.
- Ran for about 1 year 3 months before it stopped.
- 604 participants enrolled.
- Results were posted on the registry 8 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Lung Diseases; Pulmonary Disease, Chronic Obstructive
- Interventions
- MK-0873 2.5 mg; MK-0873 1.25 mg; MK-0873 0.75 mg; Placebo to MK-0873; Usual Care
- Participants
- 604
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.